Literature DB >> 32277436

Abnormal cortical regions and subsystems in whole brain functional connectivity of mild cognitive impairment and Alzheimer's disease: a preliminary study.

Bo Chen1.   

Abstract

The disease roots of Alzheimer's disease (AD) are unknown. Functional connection (FC) methodology based on functional MRI data is an effective lever to investigate macroscopic neural activity patterns. However, regional properties of brain architecture have been less investigated by special markers of graph indexes in general mental disorders. In terms of the set of the abnormal edges in the FCs matrix, this paper introduces the strength index (S-scores) of region centrality on the principle of holism. Then, the important process is to investigate the S-scores of regions and subsystems in 36 healthy controls, 38 mild cognitive impairment (MCI) patients and 34 AD patients. At the edge level, abnormal FCs is numerically increasing progressively from MCI to AD brains. At the region level, the CUN.L, PAL.R, THA.L, and TPOsup.R regions are highlighted with abnormal S-scores in MCI patients. By comparison, more regions are abnormal in AD patients, which are PreCG.L, INS.R, DCG.L, AMYG.R, IOG.R, FFG.L, PoCG.L, PCUN.R, TPOsup.L, MTG.L, and TPOmid.L. Importantly, the regions in DMN have abnormal S-scores in AD groups. At the module level, the S-scores of frontal, parietal, occipital lobe, and cerebellum are found in MCI and AD patients. Meanwhile, the abnormal lateralization is inferred because of the S-scores of left and top hemisphere in the AD group. Though this is strictly a contrastive study, the S-score may be a meaningful imaging marker for excavating AD psychopathology.

Entities:  

Keywords:  Alzheimer’s disease; Cerebral cortex; Computing methodologies; Functional connectivity

Mesh:

Year:  2020        PMID: 32277436     DOI: 10.1007/s40520-020-01539-7

Source DB:  PubMed          Journal:  Aging Clin Exp Res        ISSN: 1594-0667            Impact factor:   3.636


  98 in total

1.  The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Guy M McKhann; David S Knopman; Howard Chertkow; Bradley T Hyman; Clifford R Jack; Claudia H Kawas; William E Klunk; Walter J Koroshetz; Jennifer J Manly; Richard Mayeux; Richard C Mohs; John C Morris; Martin N Rossor; Philip Scheltens; Maria C Carrillo; Bill Thies; Sandra Weintraub; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

Review 2.  Mild cognitive impairment.

Authors:  Serge Gauthier; Barry Reisberg; Michael Zaudig; Ronald C Petersen; Karen Ritchie; Karl Broich; Sylvie Belleville; Henry Brodaty; David Bennett; Howard Chertkow; Jeffrey L Cummings; Mony de Leon; Howard Feldman; Mary Ganguli; Harald Hampel; Philip Scheltens; Mary C Tierney; Peter Whitehouse; Bengt Winblad
Journal:  Lancet       Date:  2006-04-15       Impact factor: 79.321

Review 3.  Alzheimer's disease.

Authors:  Kaj Blennow; Mony J de Leon; Henrik Zetterberg
Journal:  Lancet       Date:  2006-07-29       Impact factor: 79.321

Review 4.  Alzheimer's disease.

Authors:  Henry W Querfurth; Frank M LaFerla
Journal:  N Engl J Med       Date:  2010-01-28       Impact factor: 91.245

Review 5.  Alzheimer's disease.

Authors:  Clive Ballard; Serge Gauthier; Anne Corbett; Carol Brayne; Dag Aarsland; Emma Jones
Journal:  Lancet       Date:  2011-03-01       Impact factor: 79.321

6.  Network physiology reveals relations between network topology and physiological function.

Authors:  Amir Bashan; Ronny P Bartsch; Jan W Kantelhardt; Shlomo Havlin; Plamen Ch Ivanov
Journal:  Nat Commun       Date:  2012-02-28       Impact factor: 14.919

7.  Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.

Authors:  Bruno Dubois; Howard H Feldman; Claudia Jacova; Harald Hampel; José Luis Molinuevo; Kaj Blennow; Steven T DeKosky; Serge Gauthier; Dennis Selkoe; Randall Bateman; Stefano Cappa; Sebastian Crutch; Sebastiaan Engelborghs; Giovanni B Frisoni; Nick C Fox; Douglas Galasko; Marie-Odile Habert; Gregory A Jicha; Agneta Nordberg; Florence Pasquier; Gil Rabinovici; Philippe Robert; Christopher Rowe; Stephen Salloway; Marie Sarazin; Stéphane Epelbaum; Leonardo C de Souza; Bruno Vellas; Pieter J Visser; Lon Schneider; Yaakov Stern; Philip Scheltens; Jeffrey L Cummings
Journal:  Lancet Neurol       Date:  2014-06       Impact factor: 44.182

Review 8.  Computational psychiatry.

Authors:  Xiao-Jing Wang; John H Krystal
Journal:  Neuron       Date:  2014-11-05       Impact factor: 17.173

Review 9.  Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies.

Authors:  Kurt R Brunden; John Q Trojanowski; Virginia M-Y Lee
Journal:  Nat Rev Drug Discov       Date:  2009-10       Impact factor: 84.694

10.  Revising the definition of Alzheimer's disease: a new lexicon.

Authors:  Bruno Dubois; Howard H Feldman; Claudia Jacova; Jeffrey L Cummings; Steven T Dekosky; Pascale Barberger-Gateau; André Delacourte; Giovanni Frisoni; Nick C Fox; Douglas Galasko; Serge Gauthier; Harald Hampel; Gregory A Jicha; Kenichi Meguro; John O'Brien; Florence Pasquier; Philippe Robert; Martin Rossor; Steven Salloway; Marie Sarazin; Leonardo C de Souza; Yaakov Stern; Pieter J Visser; Philip Scheltens
Journal:  Lancet Neurol       Date:  2010-10-09       Impact factor: 44.182

View more
  2 in total

1.  Pathogenic Factors Identification of Brain Imaging and Gene in Late Mild Cognitive Impairment.

Authors:  Xia-An Bi; Lou Li; Ruihui Xu; Zhaoxu Xing
Journal:  Interdiscip Sci       Date:  2021-06-09       Impact factor: 2.233

2.  Functional Neural Alterations in Pathological Internet Use: A Meta-Analysis of Neuroimaging Studies.

Authors:  Wei Peng; Qinghong Hao; Heng Gao; Yang Wang; Jun Wang; Yang Tu; Siyi Yu; Hui Li; Tianmin Zhu
Journal:  Front Neurol       Date:  2022-04-18       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.